Skip to main content
. 2021 Aug 31;12:705543. doi: 10.3389/fimmu.2021.705543

Figure 3.

Figure 3

Preventive capacity of the whey protein products. Intact whey (iW)-specific IgE titres (A), iW-specific IgG1 titres (B), and Δear swelling after ear-swelling test (C) in rats that received extensively (eHW), partially hydrolysed (pHW-22.4% or pHW-7.2%) or intact (iW) whey products in drinking water or water alone as control. Analyses were performed on sera after whey product interventions on Day 35 and after the post immunisations on Day 42, 49, 56 and 64. Each symbol represents a single rat and horizontal lines indicate median (A, B) or mean (C) values. Statistically significant differences between product groups are indicated as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, and between product groups and naïve controls as #p ≤ 0.05 and ###p ≤ 0.001.